key: cord-0991213-f0m50h8t authors: Hatakeyama, Dai; Masuda, Takeshi; Miki, Ryosuke; Ohtsuki, Sumio; Kuzuhara, Takashi title: In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5 date: 2021-04-08 journal: Biochem Biophys Res Commun DOI: 10.1016/j.bbrc.2021.03.173 sha: 6acccf5d693237c98438acbbb8e3f8b9fcfc201d doc_id: 991213 cord_uid: f0m50h8t Recently, the novel coronavirus (SARS-CoV-2), which has spread from China to the world, was declared a global public health emergency, which causes lethal respiratory infections. Acetylation of several proteins plays essential roles in various biological processes, such as viral infections. We reported that the nucleoproteins of influenza virus and Zaire Ebolavirus were acetylated, suggesting that these modifications contributed to the molecular events involved in viral replication. Similar to influenza virus and Ebolavirus, the coronavirus also contains single-stranded RNA, as its viral genome interacts with the nucleocapsid (N) proteins. In this study, we report that SARS-CoV and SARS-CoV-2 N proteins are strongly acetylated by human histone acetyltransferases, P300/CBP-associated factor (PCAF), and general control nonderepressible 5 (GCN5), but not by CREB-binding protein (CBP) in vitro. Liquid chromatography-mass spectrometry analyses identified 2 and 12 acetyl-lysine residues from SARS-CoV and SARS-CoV-2 N proteins, respectively. Particularly in the SARS-CoV-2 N proteins, the acetyl-lysine residues were localized in or close to several functional sites, such as the RNA interaction domains and the M-protein interacting site. These results suggest that acetylation of SARS-CoV-2 N proteins plays crucial roles in their functions. were separated on 10% SDS-PAGE gels, which were dried on filter paper. The imaging 96 plates were exposed to the dried gels for several days. Signals were detected using a 97 fluoroimage analyzer (FLA-2000; Fuji Film). 98 99 Digestion of each sample and quantitative proteomic analysis were performed 101 as previously described [22] . Briefly, each sample was digested using the phase transfer 102 surfactant (PTS) method, as previously reported [23, 24] . Specific peptide data were 103 detected by Sequential Window Acquisition of All Theoretical Fragment-ion Mass 104 Software version 2.1 (SCIEX). The average peptide peak area of the samples in each 109 group was compared between the 4 groups. Statistical analyses were performed using 110 one-way analysis of variance (ANOVA). 111 protein was loaded onto the gel (Fig. 1A) . Acetylation status was investigated by 127 detecting β rays released from [ 14 C] in the acetyl group, which was transferred from 128 acetyl CoA to the N proteins (Fig. 1B) . As a result, CBP faintly, and PCAF and GCN5 129 strongly acetylated the N proteins (Fig. 1B) . In the SARS-CoV N protein lanes (3 and 4) , 130 double bands were detected between 43 and 52 kDa marker bands, with the SARS-CoV 131 N protein putatively degraded, and acetylated. These results showed that the SARS-CoV 132 and SARS-CoV-2 N proteins were acetylated by PCAF and GCN5 in vitro. As 133 mentioned above, the NPs of influenza A virus and Zaire Ebolavirus were acetylated by 134 PCAF and GCN5 [19, 20] . These HATs, categorized in the N-acetyltransferase family, 135 acetylate not only N-termini but also lysine residues of hundreds of non-histone proteins 136 [25], suggesting that viral N proteins are preferably acetylated by these enzymes. 137 138 proteins 140 from the N protein incubated with CBP, PCAF, or GCN5 suggested that PCAF and 145 GCN5 more strongly acetylated K267 and K389 than CBP (Figs. 2A, S1A-C, and S2). 146 These results were consistent with those of the biochemical experiments shown in Fig. 1 . 147 In the SARS-CoV-2 N protein, 13 peptides containing acetyl-lysine residues were 148 identified, and 12 acetyl-lysine residues (K61, K100, K102, K237, K248, K249, K266, 149 K355, K374, K375, K387, and K388) were identified (Figs. 2B, S1D-P, and S2). Of the 150 13 peptides, 11 peptides except for peptides 9 and 10, may be acetylated by CBP more 151 strongly than PCAF and GCN5. These results were not consistent with those of the 152 biochemical experiments shown in Fig. 1 , suggesting that some modified peptides were 153 failed to be detected by LC-MS analyses or peptide identification. Acetylation levels of 154 peptides 9 and 10 were similarly acetylated by 3 different HATs (Fig. 2B ). These 155 peptides contained the same acetyl-lysine residue K266, suggesting that K266 is a 156 strong target of acetylation catalyzed by many kinds of HATs. 157 158 The conservation of acetylation sites between SARS-CoV and SARS-CoV-2 N (1) K237, K248, and K249 of the SARS-CoV-2 N proteins: The tertiary 221 positions of K248 and K249 were clearly investigated (Fig. 4B) . However, the tetrad 222 glutamines, which are functional sites located close to K248 and K249 (Fig. 3) , were 223 out of the tertiary structural data, and we discussed the relationship between the 2 224 acetyl-lysines and the tetrad glutamines. A previous report showed that the tetrad 225 glutamines (240th to 243rd in SARS-CoV N protein, Fig. 3 ) play essential roles in 226 interacting with the viral M proteins [37]. These 4 serial glutamine residues were also 227 conserved in the SARS-CoV-2 N protein (239th to 242nd, Fig. 3 ). In the SARS-CoV-2 228 N protein, K237 and K248-K249, closely localizing upstream and downstream sides of 229 the tetrad glutamines, respectively, were acetylated (peptide 8 in Fig. 2) . Therefore, These peptides may be more acetylated by PCAF and GCN5 than CBP. (B) Quantitative 431 ratio of 13 peptides of the SARS-CoV-2 N proteins. Eleven peptides, and except for 432 peptides 9 and 10, may be acetylated by CBP more strongly than PCAF and GCN5. 433 SARS and MERS: recent 265 insights into emerging coronaviruses Isolation and characterization of a bat SARS-like 268 coronavirus that uses the ACE2 receptor A SARS-like cluster of 271 circulating bat coronaviruses shows potential for human emergence Coronaviridae Study Group of the International Committee on Taxonomy of The species Severe acute respiratory syndrome related coronavirus: 275 classifying 2019-nCoV and naming it SARS-CoV-2 Clinical features of patients infected with 2019 278 novel coronavirus in Wuhan, China Structure of the SARS coronavirus 369 nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for 370 helical packaging of viral RNA High-resolution structure and biophysical 373 characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 press Crystal structure of SARS-CoV-2 nucleocapsid 377 protein RNA binding domain reveals potential unique drug targeting sites Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein Structural insights into the mechanism 383 of RNA recognition by the N-terminal RNA-binding domain of the SARS An 408 acetylation/deacetylation-SUMOylation switch through a phylogenetically 409 conserved ψKXEP motif in the tumor suppressor HIC1 regulates transcriptional 410 repression activity Crosstalk between sumoylation and acetylation regulates 413 p53-dependent chromatin transcription and DNA binding